Nonalcoholic Steatohepatitis with Cirrhosis
📧 Sign up to get email alerts when something new happens for Nonalcoholic Steatohepatitis with Cirrhosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-30Clinical Trial Results: Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis [Phase 2, Phase 3]
Phase 2/3 trial evaluating belapectin for prevention of esophageal varices in patients with NASH cirrhosis was terminated; results have been…
-
CLINICAL_TRIALS trial_result · 2026-06-02Clinical Trial Update: A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES) [Phase 3]
Phase 3 MAESTRO-NASH-OUTCOMES study assessing resmetirom for clinical outcomes in well-compensated NASH cirrhosis is active not recruiting.
-
CLINICAL_TRIALS trial_result · 2020-10-08Clinical Trial Update: Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis [Phase 2]
Phase 2 trial evaluating GR-MD-02 for safety and efficacy in liver fibrosis with portal hypertension due to NASH cirrhosis has completed wit…